Takeda Aims for Globalisation with Purchase of Brazilian Company Multilab
By Heather Cartwright
Pharma Deals Review: Vol 2012 Issue 5 (Table of Contents)
Published: 30 May-2012
DOI: 10.3833/pdr.v2012.i5.1747 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Takeda Pharmaceutical is to acquire the Brazilian branded generics and OTC drug company Multilab Indústria e Comércio de Produtos Farmacêuticos for BRL500 M (US$246 M) upfront and up to BRL40 M (US$20 M) in future milestone payments...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018